Definition of non-responders

Biological markers

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Identification of reliable biomarkers in multiple sclerosis patients would be highly desirable to help disease activity and progression monitoring, and evaluate response to treatments. The field has gradually shifted from the aim to find the perfect surrogate marker to the construction of composite markers with higher performances, taking advantage of the technologies allowing unbiased screening (i.e., microarrays, proteomics, etc.). Despite the fact that very interesting results have been produced, no approach has yet made it to the patient's bedside.

Original languageEnglish
JournalNeurological Sciences
Volume29
Issue numberSUPPL. 2
DOIs
Publication statusPublished - Sep 2008

Fingerprint

Biomarkers
Proteomics
Multiple Sclerosis
Disease Progression
Technology
Therapeutics

Keywords

  • Biomarkers
  • Chemokines
  • Cytokines
  • Microarray
  • Multiple sclerosis

ASJC Scopus subject areas

  • Dermatology
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Definition of non-responders : Biological markers. / Furlan, Roberto.

In: Neurological Sciences, Vol. 29, No. SUPPL. 2, 09.2008.

Research output: Contribution to journalArticle

@article{adddfd10096e4e7b89445358392ccd17,
title = "Definition of non-responders: Biological markers",
abstract = "Identification of reliable biomarkers in multiple sclerosis patients would be highly desirable to help disease activity and progression monitoring, and evaluate response to treatments. The field has gradually shifted from the aim to find the perfect surrogate marker to the construction of composite markers with higher performances, taking advantage of the technologies allowing unbiased screening (i.e., microarrays, proteomics, etc.). Despite the fact that very interesting results have been produced, no approach has yet made it to the patient's bedside.",
keywords = "Biomarkers, Chemokines, Cytokines, Microarray, Multiple sclerosis",
author = "Roberto Furlan",
year = "2008",
month = "9",
doi = "10.1007/s10072-008-0940-3",
language = "English",
volume = "29",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Definition of non-responders

T2 - Biological markers

AU - Furlan, Roberto

PY - 2008/9

Y1 - 2008/9

N2 - Identification of reliable biomarkers in multiple sclerosis patients would be highly desirable to help disease activity and progression monitoring, and evaluate response to treatments. The field has gradually shifted from the aim to find the perfect surrogate marker to the construction of composite markers with higher performances, taking advantage of the technologies allowing unbiased screening (i.e., microarrays, proteomics, etc.). Despite the fact that very interesting results have been produced, no approach has yet made it to the patient's bedside.

AB - Identification of reliable biomarkers in multiple sclerosis patients would be highly desirable to help disease activity and progression monitoring, and evaluate response to treatments. The field has gradually shifted from the aim to find the perfect surrogate marker to the construction of composite markers with higher performances, taking advantage of the technologies allowing unbiased screening (i.e., microarrays, proteomics, etc.). Despite the fact that very interesting results have been produced, no approach has yet made it to the patient's bedside.

KW - Biomarkers

KW - Chemokines

KW - Cytokines

KW - Microarray

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=53649099369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53649099369&partnerID=8YFLogxK

U2 - 10.1007/s10072-008-0940-3

DO - 10.1007/s10072-008-0940-3

M3 - Article

VL - 29

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - SUPPL. 2

ER -